1. Adiwinata, R., Kristanto, A., Christianty, F., et al. 2015.

Tatalaksana Terkini
Perlemakan Hati Non Alkoholik. Jurnal Penyakit Dalam Indonesia Vol. 2 No. 1.
2. Alqahtani, S. A dan Schattenberg, J. M. 2020. Liver Injury in COVID-19: The
Current Evidence. United European Gastroenterology Journal Vol. 8 No. 5.
3. American Pharmacists Association. 2009. Drug Information Handbook 17th
Edition. New York: Lexi Comp Inc.
4. Anonim. 2007. Pedoman Cairan Infus Edisis Revisi IX. Jakarta: PT. Otsuka
Indonesia.
5. Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. 2019. Burden of liver
diseases in the world. In Journal of Hepatology.
https://doi.org/10.1016/j.jhep.2018.09.014
6. Caturano A., Acierno, C., Nevola, R., et al. 2021. Non-Alcoholic Fatty Liver
Disease: From Pathogenesis to Clinical Impact : A Review. Processes 2021, 9,
135.https://doi.org/10.3390/pr9010135
7. Chavez-Tapia, N. C., Barrientos, G. T., Tellez, A., et al. 2010. Antibiotic
prophylaxis dor cirrjocic patients with upper gastrointestinal bleeding (review).
The Cochrane Library, 9, 1-69.
8. Dancygier, H. 2014. Spontaneous bacterial peritonitis. In: Ahmad, J., Friedman,
S. L., dan Dancygier, H. Mount Sinai Expert Guides Hepatology. UK: John Wiley &
Sons, Ltd 227-234.
9. Dipiro, J. T., Wells, B. G., Schwinghammer, T. L., et al. 2017. Pharmacotherapy
Handbook 10th Edition. USA : McGraw-Hill Education.
10. EASL. 2016. EASL–EASD–EASO Clinical Practice Guidelines for the management
of non-alcoholic fatty liver disease. Journal of Hepatology 2016 vol. 64: 1388–
1402.
11. EASL. 2018. EASL Clinical Practice Guidelines for the management of patients
with decompensated cirrhosis. Journal of Hepatology 2018 vol. 69 406–460.
12. Febriana, Lydia. 2021. Potensi Suplemen dalam Tatalaksana COVID-19. Jurnal
CDK Edisi Continuing Medical Education Vol. 48 No.2.
13. Fernandez, J. 2014. Antibiotics prophylaxis in Acute Variceal Hemorrhage. In:
Franchis, R., Dell’Era, A. Variceal Hemorrhage. New York: Springer Science +
Business Media, 123=135.
14. Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., et al. 2007. Prevention and
management of gastroesophageal varices and variceal hemorrhage in cirrhosis.
Hepatology Vol 46 No. 3.
15. Garcia-Tsao, G., Bosch, J., Groszman, RJ. 2008. Portal Hypertension and variceal
bleeding – unresolved issues. Summary of an American Association for the study
of liver diseases and European Association for the study of liver single-topic
conference. Hepatology Vol. 47: 1746-1772.
16. Gray, A., Wright, J., Goodey, V., et al. 2011. Injectable Drugs Guide. London:
Pharmaceutical Press.
17. Gustot, T. and Moreau, R. 2015. Bacterial infection in patients with cirrhosis. In:
Keaveny, A. P., Cardenas A. Complication of Cirrhosis. Springer International
Publishing 229-241.
18. Hadi, Sujono. 2013. Gastroenterologi. Bandung : PT. Alumni.
19. https://www.megawecare.co.id/produk/hati-pencernaan/maxiliv/ diakses
28/05/2021
20. https://www.dexa-medica.com/brandedmedicine/Stronger-Neo-Minophagen-C
diakses pada 24/05/21
21. https://www.kalbemed.com/product/id/88 diakses pada 24/05/21
22. Jairath, V. and Barkun, A. N. 2012. Design of clinical trials in gastrointerstinal
bleeding. In: Sung, J. Y., Kuipers, E. J., Barkun, A. N. Gasrointestinal Bleeding.
Blackwell Publishing Ltd, 280-303.
23. Katronen, A., Westerbaca, R., Berghlom, K.., Pietilainaen, 2007. Liver Fat in the
Metabolic Syndrome. J Clin Endocrinol Metab. 92, 3490–349.
24. Kementerian Kesehatan Republik Indonesia. 2019. Petunjuk Teknis Standar
Pelayanan Kefarmasian di Rumah Sakit. Jakarta : Kemenkes RI.
25. Kemenkes RI. 2020. Pedoman Pencegahan dan Pengendalian Coronavirus
Disease (COVID-19) Revisi Ke-5. Jakarta: Kementerian Kesehatan RI.
26. Kumada, Hiromitsu. 2002. Long-Term Treatment of Chronic Hepatitis C with
Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis
and Hepatocellular Carcinoma. Oncology Vol 62 suppl. 1: 94-100.
27. Laine L. Gastrointestinal bleeding. In: Braunwald F, Hauser K, Jameson L. editors.
2008. Harrisons Internal Medicine vol II. 17th ed. United States of America: Mc
Graw Hill.
28. Laine L, Jensen DM. 2012. Management of patients with ulcer bleeding. Am J
Gastroenterol Vol 107:345- 60.
29. Lelosutan, S.A., 2006. Pengalaman Dengan Glisirizin Injeksi Di RSPAD Gatot
Soebroto – Jakarta. DEXA MEDIA No. 2, Vol. 19.
30. Leontiadis GI, Sharma VK, Howden CW. 2005. Systematic review and meta-
analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ Vol. 330
(7431): 568. doi:10.1136/bmj.38356.641134.8F
31. Lukito, Johan I. 2020. Tinjauan Antivirus untuk Terapi COVID-19. Jurnal CDK Edisi
286 Vol. 47 No. 5.
32. Mansour, D and McPherson, Stuart. 2018. Management of Decompensated
Cirrhosis. Clinical Medicine 2018 Vol 18, No 2.
33. Moon, A. M., Singal, A. G., & Tapper, E. B. 2019. Contemporary Epidemiology of
Chronic Liver Disease and Cirrhosis. Clinical Gastroenterology and Hepatology,
September, 1–16. https://doi.org/10.1016/j.cgh.2019.07.060
34. Munteanu, M. A., Nagy, G. A., Mircea, P. A. 2016. Current Management of
NAFLD: A Review. Clujul Medical 2016 Vol. 89 No.1: 19-23.
35. Nugraha, Dwi A. 2017. Diagnosis dan Tatalaksana Perdarahan Saluran Cerna
Bagian Atas Non-Variseal. Jurnal CDK Edisi 252 Vo. 44 No. 5.
36. Nurdjanah, S. 2015. Sirosis Hati. Buku Ajar Ilmu Penyakit Dalam. Edisi VI. Jakarta:
Interna Publishing.
37. Parasher, Anant. 2020. COVID-19: Current understanding of its pathophysiology,
clinical presentation and treatment. Postgrad Med J 2021;97:312–320.
doi:10.1136/postgradmedj-2020-138577
38. Peraturan Pemerintah Republik Indonesia No. 47 Tahun 2021 tentang
Penyelenggaraan Bidang Perumahsakitan. 2021. Jakarta.
39. Peraturan Menteri Kesehatan Republik Indonesia No. 72 Tahun 2016 tentang
Standar Pelayanan Kefarmasian Di Rumah Sakit. 2016. Jakarta
40. Persatuan Dokter Paru Indonesia. 2020. Pedoman Tatalaksana COVID-19 Edisi 3.
Jakarta: PDPI. ISBN: 978-623-92964-9-0.
41. Rockey, D. C. 2005. Gastrointerstinal bleeding. In: Rockey, D. C.
Gastroenterology Clinics of North America. USA: Elsevier, 581-588.
42. Rossum, T. G. J., Vulto, A. G., Hop, W. C. J., et al. 1999. Pharmacokinetics of
Intravenous Glycyrrhizin After Single and Multiple Doses in Patients with Chronic
Hepatitis C Infection. Clinical Therapeutics Vol. 21 No. 12.
43. Sachar H, Vaidya K, Laaine L. 2014. Intermittenr vs continous proton pump
inhibitor therapy for high-risk bleeding ulcers-A systematic review and meta-
analysis. JAMA.
44. Salahshoori, Iman, Mobaraki-Asl, N., Seyfaee, A., et al. 2021. Overview of COVID-
19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and
Vaccines. Biologics 2021, 1, 2–40. https://doi.org/10.3390/biologics1010002
45. Sanches, S. C., Portari, G. V., Deminice, R., et al. 2010. Effects of Lecithin and
Vitamin E Supplementation on Liver Steatosis and Oxidative Stress Induced by
Chronic Ethanol Consumption in Rats. Scandinavian Journal of Laboratory
Animal Science Vo. 37 No. 3.
46. Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al.
2020. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review).
Int J Mol Med. Vol. 46 (1):17-26.
47. Smeltzer, S. C., & Bare, B. G. 2013. Buku Ajar Keperawatan Medikal Bedah. Edisi
12. Jakarta : EGC.
48. Sudoyo, Aru W., et al. 2009. Buku Ajar Ilmu Penyakit Dalam, Jilid 1, Edisi 5.
Jakarta Fakultas Kedokteran Universitas Indonesia.
49. Susilo, A., Rumende, C. M., Pitoyo, C. W., et al. 2020. Coronavirus Disease 2019:
Tinjauan Literatur Terkini . Jurnal Penyakit Dalam Indonesia Vol. 7 No. 1.
50. Sweetman, Sean C. 2009. Martindale: The Complete Drug Reference. 36 th
Edition. London: Pharmaceutical Press.
51. Teoh, A. Y. dan Lau, J. Y. W. 2012. Hematemesis melena. In: Hawkey, C. J., Bosch,
J., Richter, J., et al. Textbook of Clinical Gastroenterology and Hepatology. USA:
Wiley Balckwell Publishing, Inc. 126-131.
52. Tim Medical Mini Notes. 2017. Basic Pharmacology and Drug Notes Edisi 2017.
Makassar: MMN Publishing.
53. Vorobioff, J. D., & Groszmann, R. J. (2015). Prevention of portal hypertension:
From variceal development to clinical decompensation. Hepatology, 61(1), 375–
381. https://doi.org/10.1002/hep.27249
54. Wadood, N., Toro, A. U., Madan, A. 2021. A Review on COVID-19: The
Epidemiology, Transmission, Impact on Pregnancy and Reproductive Health and
Its Prevention. J Women’s Health Care, Vol. 10 Iss. 2 No: 514.
55. WHO. 2021a. COVID-19 Weekly Epidemiological Update (16 th May). World
Health Organization
56. WHO. 2021b. Therapeutic and Covid-19 Living Guideline 2021.
57. Wiranata, I. M., Hasmono, D., Surdijati, S., et al. 2017. Studi Penggunaan
Omeprazole pada Pasien Sirosis Hati dengan Hemetamesis Melena Rawat Inap
di RSUD Kabupaten Sidoarjo. Journal of Pharmacey Science And Practice I
Volume 4 No. 1.